PPARgamma in endothelial cells influences high fat diet-induced hypertension.
about
PPAR-γ -- a possible drug target for complicated pregnanciesVascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1Endothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency.Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotensionBioinformatic analysis of gene sets regulated by ligand-activated and dominant-negative peroxisome proliferator-activated receptor gamma in mouse aorta.Molecular determinants of the cardiometabolic phenotype.Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension.Interference with peroxisome proliferator-activated receptor-γ in vascular smooth muscle causes baroreflex impairment and autonomic dysfunction.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionCircadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction.Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment.Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseaseOpposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progressionGenetic manipulations of PPARs: effects on obesity and metabolic disease.Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Activation of peroxisome proliferator-activated receptor γ ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.PPARgamma in human and mouse physiologyLipodystrophy, Diabetes and Normal Serum Insulin in PPARγ-Deficient Neonatal Mice.Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar RatsTranscriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases.PPAR-gamma in the Cardiovascular SystemInterference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction.Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting.Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice.Germ line activation of the Tie2 and SMMHC promoters causes noncell-specific deletion of floxed allelesEndothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.PPARgamma in the endothelium regulates metabolic responses to high-fat diet in micePPARγ2 polymorphism and human health.PPARgamma and its ligands: therapeutic implications in cardiovascular disease.Loss of PPARγ in endothelial cells leads to impaired angiogenesis.Chronic inhibition of PPAR-γ signaling induces endothelial dysfunction in the juvenile lambDisruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production.Distinct functions of vascular endothelial and smooth muscle PPARgamma in regulation of blood pressure and vascular tone.Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.PPAR Gamma and Angiogenesis: Endothelial Cells Perspective.Does peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature?
P2860
Q26863678-E0DF8578-D5B2-4F12-BD23-C6E7BDD0B67EQ28508879-916BFAD9-9F48-4E33-93C4-3FEC256C586BQ33642053-36EF5EEC-A06F-43C8-B6FA-2A6BE2650910Q33692662-075BB01E-4315-4469-9186-F1AB9F86BBA9Q33772466-977A0604-321D-4D5A-9E8A-E7ACB1FC9316Q33921392-85D1A300-72C6-4E8B-AA41-A6B070C5913BQ34046462-1F789CAB-2537-473A-B203-54E29ED30F0AQ34051403-FAF2C993-C7B0-4352-A2D8-F83F393C512FQ34178976-F581C430-5F4B-4975-BEA1-0B415009A891Q34231611-334E2182-BF56-4BF7-ADCA-8972BED86C79Q34452078-944C2E01-8539-4221-A59F-BA5326356D70Q34522002-8E128EAD-FBB6-44A9-BDA1-F2F1C7A69551Q34804346-52610C77-E720-4AB9-99CF-B9A90228E7CAQ35576310-E455EC45-318D-4794-9E40-E5543FCF4104Q35623601-027538D2-4106-4AB1-A1F2-C4DAABF038C9Q35629015-2883E952-323C-4C29-8BDE-6FF156A577F4Q35636191-AD1DED48-0E1D-40E0-AC57-262C5DE53D95Q35803453-20906462-28FB-4D1C-B8C0-941745250C95Q36063081-A6375F94-6257-4F07-B304-07A39AE14320Q36099049-A49590ED-0748-4BFE-9E43-8BFCB2F5659EQ36203979-9DF19AFC-8F42-4F6A-A5D0-0370648ECFC1Q36426782-1EBF429F-3DCB-4EA6-9D67-11CDE1D1F18BQ36426786-9D6E76C7-A1BE-42F1-A1EA-03C8A54B9DB9Q36509300-6F2270A2-221E-4437-96D1-B64C0C26C031Q36510633-54195E31-2681-4497-B93B-6D1972EC33EEQ36692337-00ECCF00-B668-4ED7-9370-9974690E0D22Q36701841-7C3B31D2-1D38-4FEC-8D5A-30B2F23D64EEQ36829626-068AA66F-C549-43AA-BC2C-7F020489B6EBQ36952573-BAE4B863-9116-46A8-B92C-7AE98B00487AQ36972995-42FF356A-1AC1-4CA8-95B4-099BCFB9B3EDQ37036060-44E136AB-5167-4C2B-B81B-D5B6EC030091Q37159796-B2316DDB-E1D4-4738-8044-37A1EEB362D4Q37179467-6AAE270E-D8FB-45B7-A732-20EC1BB1F832Q37413074-6652DA82-A581-4EAF-A0B2-C1A3D4181402Q37414446-4AADEAFC-E3E0-43DA-A7CF-DE055B09E3F1Q37430999-2F09637A-FC88-4242-A9AE-6843AB9A8788Q37468639-9970084E-DD69-4532-B154-3D5F293727FEQ37474984-86777FB9-6736-45F4-8341-A1B7E51FEE57Q37521530-A8CD4D77-32F2-45F3-BDB7-631A01B966E9Q37686890-6F422503-ECCB-4714-8C1C-9D722BE3089D
P2860
PPARgamma in endothelial cells influences high fat diet-induced hypertension.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
PPARgamma in endothelial cells influences high fat diet-induced hypertension.
@en
PPARgamma in endothelial cells influences high fat diet-induced hypertension.
@nl
type
label
PPARgamma in endothelial cells influences high fat diet-induced hypertension.
@en
PPARgamma in endothelial cells influences high fat diet-induced hypertension.
@nl
prefLabel
PPARgamma in endothelial cells influences high fat diet-induced hypertension.
@en
PPARgamma in endothelial cells influences high fat diet-induced hypertension.
@nl
P2093
P1476
PPARgamma in endothelial cells influences high fat diet-induced hypertension.
@en
P2093
Christopher J Nicol
Frank J Gonzalez
Masahiro Adachi
Taro E Akiyama
P304
P356
10.1016/J.AMJHYPER.2004.10.032
P433
P577
2005-04-01T00:00:00Z